Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Gene Therapy
Data on gene therapy discussed by investigators at German Cancer Research Center, Division of Cellular Immunology
October 28th, 2008
A report, 'Activation of human T cells by a tumor vaccine infected with recombinant Newcastle disease virus producing IL-2,' is newly published data in International Journal of Oncology. According to a study from Heidelberg, Germany, "A new recombinant (rec) Newcastle disease virus (NDV) with incorporated human interleukin 2 (IL-2) as foreign therapeutic gene [rec(IL-2)] will be described. The foreign gene in rec(IL-2) did not affect the main features of NDV replication nor its tumor selectivity." "Biologically active IL-2 was produced in high amounts by tumor cells infected with rec(IL-2). Tumor vaccine cells infected by rec(IL-2) stimulated human T cells to...
Source: Cancer Weekly (2008-10-28)
|
